{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:28:31Z","timestamp":1790288911392,"version":"4.1.0"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,5,30]]},"DOI":"10.18632\/aging.205863","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T10:21:47Z","timestamp":1717064507000},"page":"9188-9203","source":"Crossref","is-referenced-by-count":14,"title":["Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation"],"prefix":"10.18632","volume":"16","author":[{"given":"Baokang","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Tianjin First Central Hospital, Nankai University, Tianjin 300192, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Bone Tumor and Soft Tissue Oncology, Tianjin Hospital of Tianjin University, Tianjin 300211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Hospital of Tianjin University, Tianjin 300211, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide.","volume":"12","author":"Soerjomataram","year":"2021","journal-title":"Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ejca.2010.11.036","article-title":"Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.","volume":"4","author":"Whelan","year":"2011","journal-title":"Eur J Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.","volume":"12","author":"Savage","year":"2009","journal-title":"Int J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"105684","DOI":"10.1016\/j.phrs.2021.105684","article-title":"Advances in targeted therapy for osteosarcoma based on molecular classification.","volume":"16","author":"Ying","year":"2021","journal-title":"Pharmacol Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies.","volume":"1","author":"Chen","year":"2021","journal-title":"J Hematol Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12885-022-09595-0","article-title":"The oncogenic role of tubulin alpha-1c chain in human tumours.","volume":"2","author":"Xu","year":"2022","journal-title":"BMC Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/152165400410182","article-title":"Pseudouridine in RNA: what, where, how, and why.","volume":"4","author":"Gray","year":"2000","journal-title":"IUBMB Life"},{"key":"9","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.chembiol.2006.09.009","article-title":"Pseudouridine synthases.","volume":"1","author":"Ferr\u00e9-D\u2019Amar\u00e9","year":"2006","journal-title":"Chem Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-021-01951-5","article-title":"HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.","volume":"4","author":"Zhao","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43018-021-00238-0","article-title":"Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis.","volume":"2","author":"Zhang","year":"2021","journal-title":"Nat Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mc.23473","article-title":"PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt\/\u03b2-catenin pathway.","volume":"6","author":"Chen","year":"2023","journal-title":"Mol Carcinog"},{"key":"13","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10620-021-06936-0","article-title":"Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K\/AKT\/mTOR Signaling Pathway.","volume":"6","author":"Wang","year":"2022","journal-title":"Dig Dis Sci"},{"key":"14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13019-023-02332-z","article-title":"Higher expression of pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis.","volume":"1","author":"Lu","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"15","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.","volume":"1","author":"Cleton-Jansen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"1","author":"He","year":"2012","journal-title":"OMICS"},{"key":"17","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma.","volume":"1","author":"Yin","year":"2020","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41587-020-00801-7","article-title":"Assessing single-cell transcriptomic variability through density-preserving data visualization.","volume":"3","author":"Cho","year":"2021","journal-title":"Nat Biotechnol"},{"key":"19","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer.","volume":"22","author":"Yu","year":"2021","journal-title":"Pharmacol Ther"},{"key":"20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fgene.2017.00193","article-title":"Analysis of the Expression of Repetitive DNA Elements in Osteosarcoma.","volume":"8","author":"K\u00f5ks","year":"2017","journal-title":"Front Genet"},{"key":"21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing.","volume":"51","author":"Tavazoie","year":"2015","journal-title":"Nature"},{"key":"22","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.","volume":"16","author":"Tavazoie","year":"2015","journal-title":"Cell"},{"key":"23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer.","volume":"2","author":"Kouzarides","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism.","volume":"2","author":"Duan","year":"2022","journal-title":"Mol Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.","volume":"1","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.tips.2022.03.008","article-title":"Decoding pseudouridine: an emerging target for therapeutic development.","volume":"4","author":"Shi","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10165","article-title":"Converting nonsense codons into sense codons by targeted pseudouridylation.","volume":"47","author":"Yu","year":"2011","journal-title":"Nature"},{"key":"28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m6A, m5C and \u03a8 RNA modifications in cancer: Novel therapeutic opportunities.","volume":"2","author":"Blanco","year":"2021","journal-title":"Mol Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"2004344","DOI":"10.1002\/advs.202004344","article-title":"Dual Inhibition of DKC1 and MEK1\/2 Synergistically Restrains the Growth of Colorectal Cancer Cells.","volume":"8","author":"Chen","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.urolonc.2020.06.026","article-title":"Pseudouridine as a novel biomarker in prostate cancer.","volume":"3","author":"Tewari","year":"2021","journal-title":"Urol Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41416-020-01045-7","article-title":"The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.","volume":"12","author":"Rakha","year":"2020","journal-title":"Br J Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/biology10111130","article-title":"The Identification of RNA Modification Gene PUS7 as a Potential Biomarker of Ovarian Cancer.","volume":"1","author":"Guo","year":"2021","journal-title":"Biology (Basel)"},{"key":"33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.","volume":"8","author":"Bishayee","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bbrc.2017.11.165","article-title":"Lycium barbarum polysaccharide protects against oxygen glucose deprivation\/reoxygenation-induced apoptosis and autophagic cell death via the PI3K\/Akt\/mTOR signaling pathway in primary cultured hippocampal neurons.","volume":"49","author":"Fei","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-022-01285-4","article-title":"Ribosome biogenesis in disease: new players and therapeutic targets.","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41467-019-10100-8","article-title":"Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease.","volume":"1","author":"Hashimoto","year":"2019","journal-title":"Nat Commun"},{"key":"37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues.","volume":"1","author":"Volarevi\u0107","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/yea.3436","article-title":"Pseudouridine synthase 7 impacts Candida albicans rRNA processing and morphological plasticity.","volume":"3","author":"Bernstein","year":"2019","journal-title":"Yeast"},{"key":"39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-022-01561-5","article-title":"Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.","volume":"2","author":"Yin","year":"2022","journal-title":"Mol Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1200\/JCO.21.01338","article-title":"Immunotherapy for Sarcoma: A Work in Progress.","volume":"4","author":"Meyer","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T11:48:19Z","timestamp":1717588099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,30]]}},"alternative-id":["205863","38819212"],"URL":"https:\/\/doi.org\/10.18632\/aging.205863","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}